Issue of Share Options

AI SummaryClose X

CelLBxHealth plc has announced the approval of up to 50,000,000 Share Options for employees, including 11,400,000 to Chief of Staff Michelle Munson, at an exercise price of 1.35 pence per Ordinary Share. These options are subject to a three-year vesting period, with one-third vesting after one year and the remainder vesting quarterly, contingent on continued employment and a share price performance target of 2.5p on 10 out of 20 consecutive trading days for the final portion. Following this issuance, the company will have outstanding options representing approximately 4.9% of its issued share capital.

Disclaimer*

UK 100

Latest directors dealings